2012 - Research topic preview
- European lead factory: Joint European compound library and screening centre - preliminary topic outline now available
- Antibiotics research to tackle resistant bacteria more
ABOUT IMI
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
5TH CALL OPEN INFO DAY - REGISTRATION OPEN
IMI will hold an Open Info Day on its 5th Call for proposals in Brussels, Belgium on Monday 27 February.
Registration is now open.
The event will focus on the 5th Call topic 'European Lead Factory: Joint European compound library and screening centre'.
PARTNER SEARCH TOOL UPDATED
IMI has updated its Partner Search Tool with the indicative topics European Lead Factory (building a joint European compound library and screening centre) and NewDrugs4BadBugs (antimicrobial resistance).
VISIT IMI'S ONGOING PROJECTS
IMI currently funds 23 projects with a combined budget of over €450 million and covering drug safety and efficacy, knowledge management, and education & training.
EDUCATION & TRAINING
IMI project SafeSciMET is launching three new courses relating to clinical safety.
More information on these and other SafeSciMET courses, as well as details of how to apply, can be found on the SafeSciMET website
IMI NEWSFLASH 
- 22/02/2012 : Sign up for the IMI webinar on the European Lead Factory topic on 5 March at 10:30 CET http://t.co/Y3YcqqXb
- 16/02/2012 : EU Health Commissioner John Dalli praises IMI in Financial Times article http://t.co/40beg5JT
NEW IMI FUNDING RULES AND SIMPLIFIED PROCEDURES
- See the press release
and factsheet - Read the revised Grant Agreement
Innovative Medicines Initiative 2010